Clinical Trial

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-16
Trial Details
NCT Number NCT07579754
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute of Mental Health (NIMH), Kamuzu University of Health Sciences, Johns Hopkins Research Project, Malawi, Washington University School of Medicine
Conditions Long-acting Injectable Cabotegravir for PrEP, Oral Pre-Exposure Prophylaxis (PrEP)
Enrollment 384 participants
Start Date 2026-07-14
Primary Completion 2028-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-15